Digital Solutions
Professionals around the world trust Pearson products to help them make informed decisions in their work to improve lives. Our selection of innovative, research-based digital tools will transform the way you work, improve your workflow, and make you more efficient.
At Pearson Clinical Assessment we understand the pressure that you’re under as a clinical practitioner, and we’re always working to ensure our products are as user-friendly and efficient as possible.
That’s why we’ve gone digital. We’re proud that our digital assessments and tools give you the ability and flexibility to score and administer on screen, plus generate reports on a wide range of assessments with just a few clicks.
The benefits of digital assessments
Your Digital Assessment Journey
What is digital assessment, and how can it benefit you and your practice? Find out below.

Explore our digital solution products
Pearson Clinical Assessment Credentials
Ambassador Credentials recognise those who understand the value and benefits of digital assessment and how to leverage Q-interactive and/or Q-global to better serve their clients and evolve their professional practice. Individuals, who earn one of these badges will become eligible to participate in a potential customer referal reward program.
Digital Solutions Decision Tree
Unsure which of our digital solutions will work best for you? Download our decision tree to identify the most suitable tool for your needs.
Digital Solutions Brochure
Discover our selection of innovative, research-based digital tools that will transform the way you work, improve your workflow, and make you more efficient.

European Union’s Medical Devices Directive 93/42EC (MDD) Accreditation
The Q Global and Q Interactive platforms are accredited under the European Union’s Medical Devices Directive 93/42EC (MDD) for the CE Mark as a Tier 1 medical device. They should only be used by licenced and qualified practitioners to assist in making professional decisions and diagnosis. Pearson’s accreditation is valid under MDD until May 2024.